Rockville, Md., March 17, 2008 — The U.S. Pharmacopeial (USP) Convention today announced a revised Glycerin monograph in the United States Pharmacopeia (USP), an official compendium of the United ...
The cover story of this issue of Pharmaceutical Technology is devoted to over-the-counter (OTC) medications—how they're regulated, and what safeguards are in place to help ensure their quality and ...
Ganeden Biotech is pleased to announce that GanedenBC 30 (Bacillus coagulans GBI-30, 6086) is the first probiotic to have a monograph published in the Food Chemical Codex (FCC) from the U.S.
USP's Stage 2 heparin monograph revisions address identification, potency, and impurities. In January 2008, the US Centers for Disease Control and Prevention (CDC), along with the Food and Drug ...
Metrohm USA is proud to partner with the United States Pharmacopeia (USP) and host a webinar describing the USP monograph modernization program and the impact of this program for analytical ...
Rockville, Md., November 15, 2007 — The U.S. Pharmacopeia (USP) is pleased to announce 11 new proposed monographs for dietary supplements for public notice and comment. Six Turmeric-related monographs ...
A new study released in the journal PLOS One found that on average, drugs with a public quality standard developed by the U.S. Pharmacopeia had approximately 50% more generic manufacturers compared ...
Atorvastatin, a widely prescribed statin drug, is used to lower cholesterol levels and reduce the risk of cardiovascular diseases.1,2 To ensure the safety and efficacy of this drug, it is essential to ...
Within the pharmaceutical industry, compendial LC methods are used to assess whether the regulatory specifications for finished products are met. Insulin, a polypeptide hormone consisting of two ...
On March 12, 2020, an Appeals Panel of the United States Pharmacopeial Convention (“USP”) granted appeals to revisions of two compounding standards—General Chapter <795> Pharmaceutical Compounding – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results